Trademark: 97905484
Word
IAMBIC THERAPEUTICS
Status
Pending
Status Code
680
Status Date
Wednesday, September 25, 2024
Serial Number
97905484
Mark Type
4
Filing Date
Tuesday, April 25, 2023

Trademark Owner History
IAMBIC THERAPEUTICS, INC. - 1st New Owner Before Publication
Entos, Inc. - Original Applicant

Classifications
42 research and development in the field of computational biology, bioinformatics, and genomics; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; pharmaceutical, medical, scientific, biotechnology, and biopharmaceutical research and development; technical scientific consultation and product development for others in the field of biotechnology and immunology; development of pharmaceuticals; research and development of pharmaceutical preparations and substances for use in clinical trials; scientific and technological services, namely, research and design in the field of computational chemistry, machine learning and artificial intelligence for use in chemistry, biology, physics, biochemistry, chemical engineering, and computer science, and design and optimization of molecules, materials, and drugs; chemistry services, namely, laboratory research in the fields of chemistry and design of new chemistry; chemistry services in the nature of drug, and molecular discovery services, and product development services; chemical research and chemistry consultation in the field of drug and molecular development; industrial analysis and research services being scientific research in the field of drug, materials, and molecular development; technical data analysis services being technology advisory services relating to computer programs for use in chemistry, biology, physics, biochemistry, chemical engineering, computer science, and the discovery of new molecules, materials, drugs, and machine learning techniques; computer programming in the fields of molecular, materials, and drug development; computer consultancy services being computer software consultation in the field of drug, materials, and molecular development; computer software consultation services, namely, assistance and consulting in connection with the development of computer applications, databases and systems for use in the field of drug, materials, and molecular development; consulting services in the design and implementation of computer-based information systems for business, namely, provision of online information relating to computer hardware and software design in the field of drug, materials, and molecular development; creation, maintenance, hosting, and design of websites in the field of drug, materials, and molecular development; provision of online non-downloadable software for simulations for drug, materials, and molecular discovery; software as a service (SAAS) services featuring computer software platforms for use in optimizing drug, materials, and molecular discovery; platform as a service (PAAS) featuring computer software platforms for use in optimizing drug, materials, and molecular discovery; creating website based indexes of information for others using information technology for use in the field of drug, materials, and molecular development; computer graphics design services, namely, realization of computer graphics and digital imaging for use in the field of drug, materials, and molecular development; scientific research in connection with computerized automation of technical processes for use in the field of drug, materials, and molecular development; software as a services (SAAS) services in the nature of hosting cloud-based computing featuring software for optimizing the development of new molecules and designing and discovering molecules, drugs, battery materials, and other molecular products
THERAPEUTICS

Trademark Events
Apr 28, 2023
New Application Entered
Jun 28, 2023
Automatic Update Of Assignment Of Ownership
May 23, 2023
New Application Office Supplied Data Entered
Apr 1, 2024
Teas/Email Correspondence Entered
Apr 1, 2024
Correspondence Received In Law Office
Apr 1, 2024
Teas Response To Office Action Received
Jan 23, 2024
Assigned To Examiner
Jan 23, 2024
Non-Final Action Written
Jan 23, 2024
Non-Final Action E-Mailed
Jan 23, 2024
Notification Of Non-Final Action E-Mailed
Apr 17, 2024
Notification Of Non-Final Action E-Mailed
Apr 17, 2024
Non-Final Action Written
Apr 17, 2024
Non-Final Action E-Mailed
Jul 16, 2024
Application Extension To Response Period - Received
Jul 16, 2024
Application Extension Granted/Receipt Provided
Sep 13, 2024
Teas/Email Correspondence Entered
Sep 13, 2024
Teas Response To Office Action Received
Sep 25, 2024
Approved For Pub - Principal Register
Sep 13, 2024
Correspondence Received In Law Office

Trademark Alertz updated from USPTO on 2030-01-24